Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms.
Saved in:
| Title: | Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms. |
|---|---|
| Authors: | Devillier R; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France., Raffoux E; Adult Haematology Department, Saint Louis Hospital, Paris, France., Rey J; Haematology Department, Institut Paoli Calmettes, Marseille, France., Lengline E; Adult Haematology Department, Saint Louis Hospital, Paris, France., Ronchetti AM; Adult Haematology Department, Saint Louis Hospital, Paris, France., Sebert M; Senior Haematology Department, Saint Louis Hospital, Paris, France., Boissel N; Adolescents and Young Adults Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France., Robin M; Allo Stem Cell Transplantation Department, Saint Louis Hospital, Paris, France., Vey N; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France., Kiladjian JJ; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.; Centre d'Investigation Clinique (CIC), Saint Louis Hospital, Paris, France., Dombret H; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France., Cluzeau T; Adult Haematology Department, Saint Louis Hospital, Paris, France. cluzeau.thomas@gmail.com.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France. cluzeau.thomas@gmail.com.; INSERM U1065, Centre mediterraneen de Medecine Moleculaire, Nice, France. cluzeau.thomas@gmail.com. |
| Source: | British journal of haematology [Br J Haematol] 2016 Feb; Vol. 172 (4), pp. 628-30. Date of Electronic Publication: 2015 Jun 10. |
| Publication Type: | Letter; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26061174 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Devillier+R%22">Devillier R</searchLink>; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Raffoux+E%22">Raffoux E</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rey+J%22">Rey J</searchLink>; Haematology Department, Institut Paoli Calmettes, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Lengline+E%22">Lengline E</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ronchetti+AM%22">Ronchetti AM</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sebert+M%22">Sebert M</searchLink>; Senior Haematology Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Boissel+N%22">Boissel N</searchLink>; Adolescents and Young Adults Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.<br /><searchLink fieldCode="AU" term="%22Robin+M%22">Robin M</searchLink>; Allo Stem Cell Transplantation Department, Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vey+N%22">Vey N</searchLink>; Haematology Department, Institut Paoli Calmettes, Marseille, France.; Aix-Marseille University, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.; Centre d'Investigation Clinique (CIC), Saint Louis Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dombret+H%22">Dombret H</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cluzeau+T%22">Cluzeau T</searchLink>; Adult Haematology Department, Saint Louis Hospital, Paris, France. cluzeau.thomas@gmail.com.; EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France. cluzeau.thomas@gmail.com.; INSERM U1065, Centre mediterraneen de Medecine Moleculaire, Nice, France. cluzeau.thomas@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2016 Feb; Vol. 172 (4), pp. 628-30. <i>Date of Electronic Publication: </i>2015 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26061174 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.13516 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 628 Titles: – TitleFull: Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Devillier R – PersonEntity: Name: NameFull: Raffoux E – PersonEntity: Name: NameFull: Rey J – PersonEntity: Name: NameFull: Lengline E – PersonEntity: Name: NameFull: Ronchetti AM – PersonEntity: Name: NameFull: Sebert M – PersonEntity: Name: NameFull: Boissel N – PersonEntity: Name: NameFull: Robin M – PersonEntity: Name: NameFull: Vey N – PersonEntity: Name: NameFull: Kiladjian JJ – PersonEntity: Name: NameFull: Dombret H – PersonEntity: Name: NameFull: Cluzeau T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2016 Feb Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 172 – Type: issue Value: 4 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |